文献速递类风湿关节炎

类风湿关节炎合并继发性免疫缺陷患者中IEI相关基因罕见变异

Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency.
PubMed 文献 · RMD Open · 2026-07-03

该研究筛查701例类风湿关节炎(RA)患者,发现70例(10%)存在继发性免疫缺陷(SID),其中15/70(21.4%)携带17个IEI相关基因的罕见变异,7/17(41.2%)涉及经典NF-κB信号通路。SID与早发RA、血清阴性及利妥昔单抗治疗相关,提示部分RA患者的免疫缺陷可能源于潜在IEI遗传易感。

要点

  • RA患者中SID发生率为10%,与早发、血清阴性及利妥昔单抗治疗相关。
  • SID患者中21.4%携带IEI相关基因罕见变异,多为单等位基因。
  • 41.2%的变异涉及经典NF-κB信号通路,提示潜在遗传易感。

核心结论

  • 尽管罕见,潜在IEI可解释部分RA患者的免疫缺陷,识别IEI对指导免疫调节治疗选择和预防感染并发症有重要意义。

研究设计与样本

  • 筛查701例RA患者的SID(定义为持续性低丙种球蛋白血症或需预防性抗感染治疗的感染易感性),对SID患者行靶向全外显子测序识别IEI相关基因罕见变异。

主要发现

  • 701例中70例(10%)存在SID,SID在早发RA、血清阴性及接受利妥昔单抗治疗的患者中更常见。
  • 15/70例SID患者(21.4%)检出17个推定致病性变异,均为单等位基因,其中7/17(41.2%)涉及经典NF-κB信号通路。
  • 2例(3.1%)携带既往报道为致病性的变异。

关键数值与推荐

  • SID定义为持续性低丙种球蛋白血症或需预防性抗感染治疗的感染易感性。
  • SID患者中IEI相关基因罕见变异检出率为21.4%(15/70)。
  • 致病性变异中41.2%(7/17)涉及经典NF-κB信号通路。

临床怎么用

  • 对RA合并SID患者可考虑IEI相关基因检测,以指导免疫调节治疗选择并预防感染并发症。
  • 异常感染事件除考虑药物安全性外,还应警惕潜在胚系缺陷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as hypogammaglobulinaemia and severe/recurrent infections, occur in only a minority of patients, suggesting a potential underlying genetic predisposition. Given the expanding spectrum of genes implicated in inborn errors of immunity (IEIs) and the fact that IEIs can present with rheumatic manifestations, we hypothesised that a subset of patients with RA with SID harbour IEI-related variants. METHODS: We screened 701 patients with RA for SID, defined as persistent hypogammaglobulinaemia or susceptibility to infections requiring prophylactic anti-infective therapy. Patients with SID underwent targeted whole-exome sequencing to identify rare variants in IEI-associated genes. RESULTS: Among 701 evaluated patients, 70 (10%) had SID. SID was more frequently observed in patients with earlier onset of RA, seronegative disease and in those receiving rituximab therapy. Genetic analysis identified 17 putatively pathogenic variants in 15 of 70 patients with SID (21.4%). All variants were monoallelic, with 7 of 17 (41.2%) affecting genes involved in canonical NF-κB signalling. Two patients (3.1%) harboured variants previously reported as pathogenic. CONCLUSIONS: Although rare, underlying IEIs can account for immunodeficiency in patients with RA. Identifying patients with IEIs among those with RA may have important implications for disease management, as it can guide the selection of immunomodulatory therapy and help prevent infectious complications. Furthermore, it may refine our interpretation of drug safety, particularly in cases of unusual infections that may instead be attributable, rather, to an underlying germline defect.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Atschekzei F, Dubrowinskaja N, Anim M, et al. Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency. RMD Open. 2026. PMID: 42399081. doi:10.1136/rmdopen-2026-007046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。